Assessment of YME1L and mitofusin2 as a possible diagnostic and/or therapeutic target in hepatocellular carcinoma. Indian Journal of Biochemistry and Biophysics (IJBB), [S. l.], v. 60, n. 1, p. 43–54, 2023. DOI: 10.56042/ijbb.v60i1.62503. Disponível em: https://or.niscpr.res.in/index.php/IJBB/article/view/3229. Acesso em: 15 may. 2026.